Get started
Wave Life Sciences Ltd.Wave Life Sciences Ltd.Wave Life Sciences Ltd.

Wave Life Sciences Ltd.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

WVE chart


Full chart

WVE upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.17 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.11 USD
Net income (FY)
‪−57.51 M‬ USD
Revenue (FY)
‪113.31 M‬ USD
Shares float
‪118.09 M‬
Beta (1Y)
2.39

Employees


Employees (FY)
268
Change (1Y)
+16 +6.35%
Revenue / Employee (1Y)
‪422.78 K‬ USD
Net income / Employee (1Y)
‪−214.60 K‬ USD

About Wave Life Sciences Ltd.


Sector
Health Technology
Industry
Biotechnology
CEO
Paul B. Bolno
Website
wavelifesciences.com
Headquarters
Singapore
Founded
2012
ISIN
SG9999014716
FIGI
BBG00B642V54
Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

WVE news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of WVE is 14.26 USD — it has increased by 10.58% in the past 24 hours. Watch Wave Life Sciences Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Wave Life Sciences Ltd. stocks are traded under the ticker WVE.
WVE stock has fallen by −5.08% compared to the previous week, the month change is a −3.07% fall, over the last year Wave Life Sciences Ltd. has showed a 174.76% increase.
We've gathered analysts' opinions on Wave Life Sciences Ltd. future price: according to them, WVE price has a max estimate of 36.00 USD and a min estimate of 15.00 USD. Watch WVE chart and read a more detailed Wave Life Sciences Ltd. stock forecast: see what analysts think of Wave Life Sciences Ltd. and suggest that you do with its stocks.
WVE reached its all-time high on Sep 25, 2018 with the price of 56.00 USD, and its all-time low was 1.16 USD and was reached on May 23, 2022. View more price dynamics on WVE chart.
See other stocks reaching their highest and lowest prices.
WVE stock is 4.55% volatile and has beta coefficient of 2.39. Track Wave Life Sciences Ltd. stock price on the chart and check out the list of the most volatile stocks — is Wave Life Sciences Ltd. there?
Today Wave Life Sciences Ltd. has the market capitalization of ‪2.17 B‬, it has increased by 11.90% over the last week.
Yes, you can track Wave Life Sciences Ltd. financials in yearly and quarterly reports right on TradingView.
Wave Life Sciences Ltd. is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
WVE earnings for the last quarter are −0.47 USD per share, whereas the estimation was −0.28 USD resulting in a −66.20% surprise. The estimated earnings for the next quarter are −0.19 USD per share. See more details about Wave Life Sciences Ltd. earnings.
Wave Life Sciences Ltd. revenue for the last quarter amounts to ‪−7.68 M‬ USD, despite the estimated figure of ‪16.61 M‬ USD. In the next quarter, revenue is expected to reach ‪27.54 M‬ USD.
WVE net income for the last quarter is ‪−61.78 M‬ USD, while the quarter before that showed ‪−32.92 M‬ USD of net income which accounts for −87.65% change. Track more Wave Life Sciences Ltd. financial stats to get the full picture.
No, WVE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 268.00 employees. See our rating of the largest employees — is Wave Life Sciences Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Wave Life Sciences Ltd. EBITDA is ‪−143.36 M‬ USD, and current EBITDA margin is −51.89%. See more stats in Wave Life Sciences Ltd. financial statements.
Like other stocks, WVE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Wave Life Sciences Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Wave Life Sciences Ltd. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Wave Life Sciences Ltd. stock shows the buy signal. See more of Wave Life Sciences Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.